105 related articles for article (PubMed ID: 15168787)
1. Synthesis and alkylation activity of a nitrogen mustard agent to penetrate the blood-brain barrier.
Bartzatt RL
Drug Deliv; 2004; 11(1):19-26. PubMed ID: 15168787
[TBL] [Abstract][Full Text] [Related]
2. A bifunctional alkylating nitrogen mustard agent that utilizes barbituric acid as carrier drug with the potential for crossing the brain-blood barrier.
Bartzatt R; Donigan L
Recept Channels; 2003; 9(5):309-13. PubMed ID: 14527874
[TBL] [Abstract][Full Text] [Related]
3. Utilizing a D-amino acid as a drug carrier for antineoplastic nitrogen mustard groups.
Bartzatt RL
Drug Deliv; 2005; 12(3):141-7. PubMed ID: 16025843
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of aromatic nitrogen mustard agents and analysis of their alkylation activity at physiological pH and temperature.
Bartzatt R; Kasher L
Physiol Chem Phys Med NMR; 2002; 34(2):103-17. PubMed ID: 12841328
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional constructs of aspirin and ibuprofen (non-steroidal anti-inflammatory drugs; NSAIDs) that express antibacterial and alkylation activities.
Bartzatt R; Cirillo SL; Cirillo JD; Donigan L
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):273-82. PubMed ID: 12533193
[TBL] [Abstract][Full Text] [Related]
6. Alkylation activity and molecular properties of two antineoplastic agents that utilise indometacin and a conjugate of aspirin with 2-aminonicotinic acid to transport nitrogen mustard groups.
Bartzatt R
Drugs R D; 2007; 8(6):363-72. PubMed ID: 17963427
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and reactivity of aryl nitrogen mustard-oligodeoxyribonucleotide conjugates.
Reed MW; Lukhtanov EA; Gorn V; Kutyavin I; Gall A; Wald A; Meyer RB
Bioconjug Chem; 1998; 9(1):64-71. PubMed ID: 9460548
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure-activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents.
Li DD; Dai LL; Zhang N; Tao ZW
Bioorg Med Chem Lett; 2015 Oct; 25(19):4092-6. PubMed ID: 26299348
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
Xie G; Gupta R; Lown JW
Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of Hoechst 33258 analogues.
Gupta R; Wang H; Huang L; Lown JW
Anticancer Drug Des; 1995 Jan; 10(1):25-41. PubMed ID: 7535056
[TBL] [Abstract][Full Text] [Related]
11. Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies.
Baraldi PG; Beria I; Cozzi P; Geroni C; Espinosa A; Gallo MA; Entrena A; Bingham JP; Hartley JA; Romagnoli R
Bioorg Med Chem; 2004 Jul; 12(14):3911-21. PubMed ID: 15210158
[TBL] [Abstract][Full Text] [Related]
12. Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.
Su TL; Lin YW; Chou TC; Zhang X; Bacherikov VA; Chen CH; Liu LF; Tsai TJ
J Med Chem; 2006 Jun; 49(12):3710-8. PubMed ID: 16759114
[TBL] [Abstract][Full Text] [Related]
13. Two lead drug designs based on chloramphenicol as the parent structure, which express alkylation activity with potential for clinical applications.
Bartzatt R
J Pharm Pharmacol; 2003 May; 55(5):653-60. PubMed ID: 12831508
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship for alkylating dipeptide nitrogen mustard derivatives.
Gullbo J; Tullberg M; Våbenø J; Ehrsson H; Lewensohn R; Nygren P; Larsson R; Luthman K
Oncol Res; 2003; 14(3):113-32. PubMed ID: 14760861
[TBL] [Abstract][Full Text] [Related]
15. DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin.
Broggini M; Coley HM; Mongelli N; Pesenti E; Wyatt MD; Hartley JA; D'Incalci M
Nucleic Acids Res; 1995 Jan; 23(1):81-7. PubMed ID: 7870593
[TBL] [Abstract][Full Text] [Related]
16. Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil.
Genka S; Deutsch J; Shetty UH; Stahle PL; John V; Lieberburg IM; Ali-Osman F; Rapoport SI; Greig NH
Clin Exp Metastasis; 1993 Mar; 11(2):131-40. PubMed ID: 8444006
[TBL] [Abstract][Full Text] [Related]
17. Applying pattern recognition methods to analyze the molecular properties of a homologous series of nitrogen mustard agents.
Bartzatt R; Donigan L
AAPS PharmSciTech; 2006 Apr; 7(2):E35. PubMed ID: 16796353
[TBL] [Abstract][Full Text] [Related]
18. Alkylating properties of phosphoramide mustard.
Colvin M; Brundrett RB; Kan MN; Jardine I; Fenselau C
Cancer Res; 1976 Mar; 36(3):1121-6. PubMed ID: 1253171
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pyridine-3-carboxylic acid as a drug carrier by utilizing multivariate methods, structure property correlations, and pattern recognition techniques.
Bartzatt RL
Recept Channels; 2004; 10(2):61-71. PubMed ID: 15204036
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of propranolol mustard as a possible lung-specific antitumor agent.
Feyns LV; Beisler JA; Driscoll JS; Adamson RA
J Pharm Sci; 1980 Feb; 69(2):190-2. PubMed ID: 7359322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
